Local anesthesia: Give it time or try a buffered anesthetic
Mic Falkel, DDS, has spent a considerable amount of time studying anesthesia. Yet the presenter at the recent Greater New York Dental Meeting was humbled
Mic Falkel, DDS, has spent a considerable amount of time studying anesthesia. Yet the presenter at the recent Greater New York Dental Meeting was humbled
The U.S. Food and Drug Administration (FDA) is planning to recommend a more restrictive classification of hydrocodone combination drugs to increase control of the drugs,
Fear of the needle has many origins, but in the case of palatal anesthetic injections, the reputation of a painful experience during dentistry is more
New research on propofol, the most commonly used anesthetic drug, may help scientists design new versions of the drug that reduce the risks involved in
Some oral and maxillofacial surgeons (OMSs) may be inadvertently contributing to the improper consumption or sale of prescription pain medications, according to a new study
A San Diego man who went into cardiac arrest during routine third-molar extractions was given a combination of anesthetics that might have led to his
Patient fear of the needle is a regular obstacle for dental professionals. Now St. Renatus, a Colorado start-up, is navigating the U.S. Food and Drug Administration
Stroke patients do not need to discontinue taking blood thinners such as aspirin and warfarin prior to undergoing dental procedures, according to a new guideline
Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn’t increase the rate of complications and death, and might even decrease the risk
Abuse of propofol is a “rapidly progressive form of substance dependence” that is being more commonly seen among healthcare professionals, according to a study to
Combining mannitol with lidocaine significantly increases the effectiveness of an inferior alveolar nerve block, according to a new study in Anesthesia Progress (Spring 2013, Vol.
The U.S. Food and Drug Administration (FDA) today issued a draft guidance document to assist pharmaceutical companies in developing new formulations of opioid drugs that